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Distribution of 82-adrenergic receptor mRNA expression along the microdissected hamster nephron segments was examined by the reverse 
transcription-polymerase chain reaction (RT-PCR) technique. Conventional RT-PCR using a set of primers on separate xons could not be applied 
for the detection offi2-adrenergic receptor mRNA because of its intronless nature. We used the ‘rapid amplification of cDNA ends’ protocol [(1985) 
Proc. Natl. Acad. Sci. USA 85, 8998-90021 asa maneuver for RT-PCR of an intronless gene. Using this method, we successfully located hamster 
/?2-adrenergic receptor mRNA only in glomeruli and early proximal convoluted tubule along the nephron segments tested. 
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1. INTRODUCTION mRNA of the BZadrenergic receptor in both glomer- 
ulus and early proximal convoluted tube. 
The #J-adrenergic system is one of the main regulators 
of the extracellular fluid volume, and its effect on the 
kidney has been studied extensively. However, there are 
discrepancies in reported data concerning the precise 
locahzation of its receptor and the subtype of the recep- 
tor involved (see section 4). 
2. MATERIALS AND METHODS 
2.1. Materials 
Polymerase chain reaction (PCR), combined with re- 
verse transcription (RT), has realized the detection of 
mRNA from minimal tissue sample. This RT-PCR 
technique has been applied to microdissected nephron 
segments, and distribution of mRNA expression of sev- 
eral genes in the kidney has been reported [ 1,2]. Another 
advantage of this approach is that it allows the discrim- 
ination of similar proteins, such as hormone receptor 
subtypes, at the gene level. Application of this method 
for the BZadrenergic receptor gene, however, has been 
hampered by the fact that it contains no introns [3], 
because PCR of reverse-transcribed cDNA is generally 
performed using a set of primers on exons separated by 
introns in order to avoid erroneous detection of ampli- 
fied genomic DNA. 
Collagenase (type I) is the product of Sigma (St. Louis, MO, USA). 
AMV reverse transcriptase, RNase inhibitor, DNA tailing kit, digoxi- 
genin (DIG)-dUTP, positively charged nylon membrane, chemilu- 
minescent DIG detection kit, and DIG-labeled DNA weight marker 
(pBR 322 &/I + pBR 328 Hinfl) were purchased from Boehringer- 
Mannheim (Mannheim, Germany). Tuq polymerase was purchased 
from Takara Shuzo Co. (Kyoto, Japan). Oligonucleotides used for RT 
and PCR primers or the hybridization probe were synthesized using 
DNA synthesizer (391, PCR-MATE; Applied Biosystems. Foster 
City, CA, USA). and purified with Sephadex G-25 quick spin columns 
(Boehringer-Mannheim, Mannheim, Germany). Ace1 restriction en- 
zyme and its reaction buffer were purchased from Wako Chemicals 
(Osaka, Japan). 
2.2. Preparation of tissue samples 
In the present study, we examined the distribution of 
fi2-adrenergic receptor mRNA expression along the mi- 
~rodiss~ted nephron segments, by modifying the RT- 
PCR protocol for the detection of mRNA of intronless 
genes from small quantities of tissue preparations. Fol- 
lowing this approach, we have successfully located 
Golden hamsters of both sexes weighing between 50 and 100 g were 
used. Nephron segments were microdissected as previously described 
[4] with minor modifications. In brief, left kidney was perfused from 
abdominal aorta with ‘microdissection solution’ (NaCl 137 mM, KC1 
4 mM, CaCl, 1 mM, KH,PO, 1 mM, MgSO., 1 mM, glucose 5 mM, 
lactate 5 mM, HEPES 10 mM, 0.1% of bovine serum albumin (BSA), 
and pH adjusted to 7.4 with NaOH), containing 0.1% collagenase, and 
sliced with a razor blade. Tissue slices were then incubated with 0.1% 
collagenase for 30 min at 37°C. Microdissection was performed at 4°C 
in microdissection solution. Microdissected nephron segments (10 
glomeruli or 2 mm of each tubular segment) were transferred into fresh 
solution in another dish and rinsed carefully so that no cell debris or 
interstitial tissues were attached. The prepared segment was then 
transferred into a SOO@ Eppendorf tube with minimal solution (about 
t ,A). and mRNA was extracted as follows. 
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2.3. Extraction of mRNA 
Extraction of mRNA was performed by applying the acid guanidin- 
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ium-phenol-chloroform (AGPC) method reported by Chomczynski 
and Sacchi (51 with slight modificattons. 100~1 of denaturing solution 
(4 M guanidinium thiocyanate, 25 mM sodium citrate. pH 7, 0.5% 
sarcosyl, and 0.1 M Z-mercaptoethanol) was added to the tubes con- 
taining the microdissected nephron segments. Then 100 ~1 of phenol 
saturated with water (pH 4), 20 ,ul of chloroform/isoamyl alcohol 
(24:1), and 10 ~1 of 3 M sodium acetate (pH 5.3) were added, and the 
tubes were left on ice for 15 min. Samples were centrtfuged at 
20,000 x g for IO min at 4”C, the aqueous phase was extracted again 
with chloroformlisoamyl alcohol (241). and was transferred to a fresh 
tube. Then 5 fig of tRNA was added as carrier of mRNA, and the 
solution was mixed with 200 ,& of ethanol and stored at -20°C for 
precipitation. The tubes were then centrifuged, the pellet was washed 
with 70% ethanol, and centrifuged again. The pellet of RNA was used 
in the following steps. 
2.4. Reverse transeriptum and polymerare chain reaction 
Reverse transcription (RT) followed by selective amplification of 
specitic cDNA was done following the ‘rapid ~pli~cation of cDNA 
ends’ (RACE) protocoi reported by Frohman et al. [6]. The main 
strategy of this method is depicted in Fig. 1. In short, RT was per- 
formed using an oligo(dT) primer attached with an artificial adapter 
sequence, so that every antisense cDNA synthesized in this reaction 
carried the adapter sequence at the 5’ end. This adapter sequence 
primer was patred by a specific sense primer in the upstream region 
of the cDNA and used for subsequent PCR. where only the target 
cDNA was amplified. 
The RT reaction was performed as follows. The pellet m the ethanol 
precipitation tube was dissolved in 17 ,ul of RT solution and divrded 
into two fresh tubes for the RT-PCR reaction (thus. the amount of the 
sample in each tube was either 5 glomeruli or 1 mm of tubular seg- 
ment). In one tube, 0.5~1 of RNase inhibitor and 1~1 of AMV reverse 
transcrtptase were added. In the other tube, 1.5 ~1 of enzyme storage 
buffer was added for use as a control without reverse transcriptase. 
The final amount of RT reaction solution was 10 ~1 and its composi- 
tion was: Tris-HCI (pH 8.3) 10 mM, KCI 50 mM, MgCl: 50 mM, 
dithiothreitol (DTT) 1 mM, primer (oligo(dT) + adapter) 1 PM, 
RNase inhibitor 5-25 U/IO& and AMV reverse transcriptase 10 U/10 
~1. RT tubes were incubated at 42°C for 60 min, and the reaction was 
terminated by heating the tubes at 95°C for 5 min. 
PCR was performed using a sense-specific primer (P-CAGG- 
CACGGAAAGCTTTGTG3’ whtch corresponds to bases 2,3?1- 
2,390 of the reported cDNA sequence of the hamster b2-adrenergtc 
receptor [7]) and adapter oligonucleotide (Fig. 1) as the antisense 
primer. PCR splutton was added to the RT tube to make a final 
volume of 50 ~1. The composition of the reaction solution was: Tris- 
HCI (pH 8.3 at room temperature) 10 mM. KC1 50 mM, MgC& 2 mM. 
gelatin O.Ol%, specific sense primer 200 nM, tait adapter primer 200 
nM, dNTPs 0.2 mM each. and Taq polymerase 1.25 U/50 $1. Each 
cycle of PCR consisted of 93°C for 1 min of denaturating, 60°C for 
1.5 min of annealing, and 72*C for 2 min of extension, and was 
repeated up to 40 cycles. 
In most of the,experiments, econd step or nested PCR was per- 
formed. In these expe~ments, the first step PCR product was used 
after IO times of’~iiution. PCR buffer composition and the reaction 
condition of eachicycle were identical with the first step PCR. The 
primers used were 5’-GTACAAATGACTCACCGCTG-3’, which 
corresponds to bases 2,4462,465 of the hamster B2-adrenergic recep- 
tor cDNA as sense primer. and 5’-TCACAGCAGAAAGGT- 
CCAAG-3’, corresponding to bases 2.863-2882 as antisense primer. 
The expected product size is 437 bp. The number of cycles ranged from 
5 to 20, depending on the objective of the study. 
2.5. Restriclian enzyne treatment of the PCR product 
In some experiments, the RT-PCR product was treated with the 
restriction enzyme ArcI, as discussed m section 3. The first step PCR 
product was extracted once with phenol/chloroform and precipitated 
with ethanol. The pellet was diluted with 20@ of AccI reaction buffer, 
and divided into 2 fresh tubes, one for the reaction and another to act 
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Fig. 1. The strategy of reverse transcription (RT) of the RACE proto- 
col. RT was performed following the RACE (rapid amplification of 
cDNA ends) protocol reported by Frohman et al. [6] with slight mod- 
ification. The primer used was a 37mer, which was composed of 
17(dT) nucleotides at the 3’ end and an artificial adapter sequence at 
the 5’ end (3’TTTTTTT’ITTTTTTTTTAGGGCTACAGCT- 
GAGCTCAG-5’). The oligo(dT) sequence of the primer matches arbi- 
trarily with any part of the poly(A) tail of mRNA and the RT reaction 
ensues. Note that every synthesized antisense cDNA has the adapter 
sequence at the 5’ end, and that the (dT)n region before the adapter 
is of variable length, depending on which part of the poly(Af site of 
mRNA the primer matched for RT. The adapter sequence primer 
(3’-GGGCTACAGCTGAGCTCAG-5’) was paired by an upstream 
specific sense primer and used for subsequent PCR. 
as a control without enzyme. I ,& of Ace1 enzyme (9 U/@) was added 
to the reaction tube and both tubes were incubated at 37°C overnight. 
The end product was analyzed by Southern hybridization. 
2.6. Detection of the PCR product 
The RT-PCR product was detected by agarose gel electrophoresrs 
and either ethidium bromide staining or Southern hybridization. The 
probe used for Southern hybridization was a sense 35mer oiigonucle- 
otide corresponding to bases 2,771-2,805 of hamster /32-adrenergic 
receptor cDNA (5’-CTCACTCGTCAAGTGTTAGGGGATACG- 
CTGCTAGT-3’) labeled with DIG-dUTP using a DNA tailing kit. 
Hybridization was performed using positively charged nylon mem- 
brane. The hybridized samples were detected by using a chemilu- 
minescent detection kit following the instructions of the manufacturer. 
3. RESULTS 
3.1. RT-PCR of intronless genes 
We selected glomeruli /32-adrenergic receptor mRNA 
as a model to ascertain the relevance of our new ap- 
proach of RT-PCR for intronless genes, since the pres- 
ence of the ~2-adr~ner~~ receptor in glomeruli has al- 
ready been demonstrated using autoradiography [8]. As 
the cDNA synthesized by the above-mentioned RT re- 
action has a variable length of dT’s just before the 
adapter (Fig. l), the PCR product was also not constant 
in its length and could not be detected as a band by 
normal gel e~~trophoresis. We used two distinct ma- 
neuvers to impose uniformity on the length of the prod- 
uct so that it could be detected by gel electrophoresis. 
One of them was to cut off the variable 3’ tail of ampli- 
fied double-stranded cDNA using a restriction enzyme. 
Hamster /X5adrenergic receptor cDNA has a restriction 
site for AccI (-GTAGAC-) at base 2,929, and it is the 
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Fig. 2. The effect of AccI treatment of the /32-adrenergic receptor 
mRNA RT-PCR product. Lane 1, DIG-labeled DNA weight marker. 
Lanes 2 and 3, results of the RT-PCR product with or without AccI 
digestion, respectively. Lanes 4 and 5, results of the RT-negative 
control with and without restriction enzyme digestion. 
only cutting site along the sequence which is amplified 
during PCR. The expected length of DNA after the 
enzyme treatment is 558 bp. Fig. 2 depicts the result of 
AccI treatment of RT-PCR product from 5 glomeruli. 
The RT-PCR product without enzyme treatment shows 
only a vague broad signal, reflecting its variable length 
(lane 3). By digesting with AccI, a single band of ex- 
pected size appeared (lane 2). In the RT-negative con- 
trol, a corresponding band cannot be seen even after 
restriction enzyme treatment (lane 4). The result implies 
that, even though the PCR product could not be de- 
tected as a band by electrophoresis, it had been suffi- 
ciently amplified during the reaction, and that the prod- 
uct has the restriction site at the expected position. 
Another method we employed for detecting the RT- 
PCR product was to amplify a part of the product using 
a set of specific primers (nested PCR). The final product 
corresponds to a sequence where both ends of the first 
step PCR product have been truncated, and is of con- 
stant length. By ethidium bromide staining of agarose 
gel, we detected a single band at about 10 cycles of 
second step PCR amplification. Southern hybridization 
revealed the signal at 5 cycles of second step PCR (Fig. 
3). This two-step PCR is sensitive, easy to perform and 
has a high degree of specificity. We used this method for 
screening the nephron distribution of mRNA. 
3.2. Nephron distribution of p2-adrenergic receptor 
mRNA 
The nephron segments tested were glomerulus, early 
proximal convoluted tubule (PCT), proximal straight 
tubule (PST), descending thin limb of Henle (DTL), 
medullary thick ascending limb (mTAL), cortical thick 
ascending limb (cTAL), distal convoluted tubule 
(DCT), cortical collecting duct (CCD), outer medullary 
collecting duct from inner stripe (OMCD), and terminal 
portion of inner medullary collecting duct (IMCD). For 
these 10 segments, we performed the two-step PCR. For 
each segment, experiments were repeated at least 5 times 
with essentially the same results. In each experiment 3-6 
different nephron segments were studied, where glomer- 
uli were always included as one of the segments and 
served as a positive control. For each segment, a sample 
without reverse transcriptase was always used as a neg- 
ative control. In order to attain maximal sensitivity, 
second step PCR was continued up to 20 cycles. 82- 
Adrenergic receptor mRNA was detected only in glom- 
erulus and early PCT. Fig. 4 depicts the results of two 
step PCR product agarose gel electrophoresis and 
Southern hybridization of 10 nephron segments. 
Since we detected /I-adrenergic receptor mRNA only 
in 2 of 10 nephron segments tested, we also examined 
a-tubulin gene (an example of a housekeeping gene) 
mRNA expression using the same protocol as reported 
here to ascertain the applicability of our method to 
negative segments. As expected, we detected its mRNA 
in all the nephron segments (data not shown). 
4. DISCUSSION 
RT-PCR of intronless genes has been reported by 
Grill0 and Margolis [93. They used DNase digestion of 
the sample prior to RT to minimize contamination of 
genomic DNA. However, the authors report faint sig- 
nals in RT-negative controls in some experiments, the 
result indicating that minor contamination of genomic 
DNA is inevitable ven after DNase treatment. We tried 
this method for microdissected nephron segments, and 
PCR products of the expected length were also seen in 
RT-negative controls only a few cycles later than in 
RT-positive samples (data not shown). The results may 
imply that, in our case, the quantity of sample mRNA 
was very small, and even after DNase treatment, the 
absolute difference between mRNA and the remaining 
DNA might have been insignificant; thus after PCR 
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Fig. 3. Two-step PCR of hamster glomerular ,82-adrenergic receptor mRNA. The figure demonstrates the results of different cycles (5, 10, 15, and 
20 cycles) of second step PCR amplification. The product of each experiment was paired by a RT-negative control for detection. The left panel 
shows the result of agarose gel electrophoresis stained with ethidium bromide. The right panel depicts the result of Southern hybridization. In each 
panel, DIG-labeled DNA weight markers are shown in lane 1, and the first step PCR products are shown in lanes 2 and 3. 
amplification, the origin of the final product became 
ambiguous. The procedure for RT-PCR of intronless 
genes by Grill0 et al. [93 may not be adequate for the 
detection of mRNA expression in minute samples uch 
as mi~rodisse~ied nephron segments. 
For intronless genes, the cDNA sequence is essen- 
tially identical to that of the genomic DNA, so that 
conventional PCR cannot distinguish between the two. 
The only possible difference is elaborated by applying 
primers matching the poly(A) tail of mRNA at the step 
of RT. Efficient amplification of thus synthesized 
cDNA is reported by Frohman et al. as the RACE 
protocol [6]. In the present study, we have successfully 
applied this approach for RT-PCR of intronless genes. 
Using the method reported here, we have located the 
jZ?-adrenergic receptor in glomeruli and early PCT mi- 
crodissected from hamster kidney. The renal #?-adrener- 
gic system has been analyzed by many authors in vari- 
ous ways. Earlier clearance studies have demonstrated 
the direct effect of the /I-adrenergic system on renal 
function [lo]. Morphological investigations have shown 
adrenergic innervation in the kidney [l I]. As for the 
precise nephron distribution of these receptors and the 
subtype involved, there are some discrepancies in the 
reported data. Cultured mesangial cells have been 
shown to respond to isoproterenol by increasing CAMP 
production [ 121. As for tubular segments, some authors 
have shown distal distribution of ,&receptors using bio- 
chemical ]I 3-151 and physiologi~l techniques [16.171, 
68 
whereas others have reported that proximal tubular seg- 
ments respond to /?-adrenergic stimuli [ 10,182 I]. Most 
of those reports used isoproterenol as the agonist and/or 
propranolol as the antagonist (with the exception of 
Murayama et al. [ZO] who demonstrated by using spe- 
cific antagonists that adrenergic receptors in microdis- 
sected PST are of the 82 subtype. and Teitelbaum et al. 
[15] who showed by using atenolol that /?-adrenergic 
receptors of subtype other than /I1 are present in cul- 
tured IMCD cells [15]), and from those studies it is not 
clear which subtype of receptors is invoived in most of 
the nephron segments. Using subtype-specific agents, 
two groups have reported the distribution of ,/31 and 82 
subtypes of adrenergic receptors in the kidney by au- 
toradiography [8,22], but their results are not totally in 
agreement with each other. Summers et al. demon- 
strated that those receptors distributing in the distal 
nephron are mainly of the/?1 subtype, while both/I1 and 
82 subtypes of receptors are present in glomeruli [8], 
data largely in agreement with our present results except 
for the lack of proximal 82 receptors. In contrast Healy 
et al. have reported that those receptors distributing in 
glome~li are mainly of the pl subtype whilst the /I2 
subtype of receptors are distributed in medullary tu- 
bules [22]. Although the reasons for the conflicting data 
reported in the literature, as well as some disagreements 
of our present results with others, may not be identified 
unequivocally, the problem of cross-reactivity of phar- 
macological agents should always be considered. We 
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Fig. 4. Nephron distribution of hamster B2-adrenergic receptor mRNA. Distribution of/72-adrenergic receptor mRNA along the hamster nephron 
was examined using a two-step PCR method. The PCR products were detected by agarose gel electrophoresis and ethidium bromide staining (left 
panel) or Southern hybridization (right panel). 
believe that the only way of definitely discriminating 
receptor subtypes is at the gene level, and RT-PCR 
should play a major role in this field. Finally, species 
difference remains as one of the candidates for some of 
the discrepancies of our data with others. 
In conclusion, we have succeeded in detecting mRNA 
of the /?Zadrenergic receptor gene, an example of an 
intronless gene, from small quantities of tissue prepara- 
tion using the RACE protocol reported by Frohman, 
with slight modifications. By applying this approach we 
have successfully located its expression in microdis- 
sected hamster glomeruli and early PCT, but not in the 
other nephron segments tudied. 
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